nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—CYP19A1—polycystic ovary syndrome	0.662	1	CbGaD
Masoprocol—CYP19A1—follicular fluid—polycystic ovary syndrome	0.0346	0.241	CbGeAlD
Masoprocol—CYP19A1—corpus luteum—polycystic ovary syndrome	0.0199	0.139	CbGeAlD
Masoprocol—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.0156	0.109	CbGeAlD
Masoprocol—IGF1R—embryo—polycystic ovary syndrome	0.00571	0.0398	CbGeAlD
Masoprocol—LTB4R—pituitary gland—polycystic ovary syndrome	0.00458	0.0319	CbGeAlD
Masoprocol—LTB4R—adipose tissue—polycystic ovary syndrome	0.00456	0.0318	CbGeAlD
Masoprocol—LTB4R—adrenal gland—polycystic ovary syndrome	0.00409	0.0285	CbGeAlD
Masoprocol—LTB4R—female gonad—polycystic ovary syndrome	0.00381	0.0266	CbGeAlD
Masoprocol—LTB4R—vagina—polycystic ovary syndrome	0.00379	0.0264	CbGeAlD
Masoprocol—IGF1R—adipose tissue—polycystic ovary syndrome	0.00377	0.0262	CbGeAlD
Masoprocol—LTB4R—endocrine gland—polycystic ovary syndrome	0.00355	0.0247	CbGeAlD
Masoprocol—IGF1R—adrenal gland—polycystic ovary syndrome	0.00338	0.0235	CbGeAlD
Masoprocol—IGF1R—female gonad—polycystic ovary syndrome	0.00315	0.0219	CbGeAlD
Masoprocol—IGF1R—vagina—polycystic ovary syndrome	0.00313	0.0218	CbGeAlD
Masoprocol—IGF1R—endocrine gland—polycystic ovary syndrome	0.00293	0.0204	CbGeAlD
Masoprocol—CYP2J2—endometrium—polycystic ovary syndrome	0.00283	0.0197	CbGeAlD
Masoprocol—CYP2J2—uterus—polycystic ovary syndrome	0.00261	0.0182	CbGeAlD
Masoprocol—CYP2J2—pituitary gland—polycystic ovary syndrome	0.00256	0.0179	CbGeAlD
Masoprocol—CYP2J2—vagina—polycystic ovary syndrome	0.00212	0.0148	CbGeAlD
Masoprocol—Fenoterol—ADRB3—polycystic ovary syndrome	0.00209	0.261	CrCbGaD
Masoprocol—ALOX5—adipose tissue—polycystic ovary syndrome	0.00201	0.014	CbGeAlD
Masoprocol—CYP2J2—endocrine gland—polycystic ovary syndrome	0.00199	0.0138	CbGeAlD
Masoprocol—Arbutamine—ADRB3—polycystic ovary syndrome	0.00195	0.244	CrCbGaD
Masoprocol—ALOX5—adrenal gland—polycystic ovary syndrome	0.0018	0.0126	CbGeAlD
Masoprocol—ALOX5—female gonad—polycystic ovary syndrome	0.00168	0.0117	CbGeAlD
Masoprocol—ALOX5—endocrine gland—polycystic ovary syndrome	0.00156	0.0109	CbGeAlD
Masoprocol—CYP19A1—endometrium—polycystic ovary syndrome	0.00154	0.0107	CbGeAlD
Masoprocol—CYP19A1—uterus—polycystic ovary syndrome	0.00142	0.0099	CbGeAlD
Masoprocol—CYP19A1—adipose tissue—polycystic ovary syndrome	0.00139	0.00969	CbGeAlD
Masoprocol—CYP19A1—adrenal gland—polycystic ovary syndrome	0.00125	0.00869	CbGeAlD
Masoprocol—CYP19A1—female gonad—polycystic ovary syndrome	0.00116	0.0081	CbGeAlD
Masoprocol—CYP19A1—endocrine gland—polycystic ovary syndrome	0.00108	0.00753	CbGeAlD
Masoprocol—Isoprenaline—ADRB3—polycystic ovary syndrome	0.00102	0.127	CrCbGaD
Masoprocol—Fenoterol—ADRB2—polycystic ovary syndrome	0.000794	0.0992	CrCbGaD
Masoprocol—Arbutamine—ADRB2—polycystic ovary syndrome	0.000743	0.0928	CrCbGaD
Masoprocol—Dobutamine—ADRB2—polycystic ovary syndrome	0.000684	0.0854	CrCbGaD
Masoprocol—Isoprenaline—ADRB2—polycystic ovary syndrome	0.000388	0.0485	CrCbGaD
Masoprocol—Isoprenaline—CYP1A1—polycystic ovary syndrome	0.000333	0.0415	CrCbGaD
Masoprocol—CYP2J2—Biological oxidations—POMC—polycystic ovary syndrome	0.000186	0.001	CbGpPWpGaD
Masoprocol—LTB4R—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000185	0.000992	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000184	0.000986	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000183	0.00098	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000183	0.00098	CbGpPWpGaD
Masoprocol—IGF1R—IGF1R signaling cascade—IL6—polycystic ovary syndrome	0.000182	0.000976	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000181	0.000972	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00018	0.000967	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00018	0.000965	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—LPCAT2—polycystic ovary syndrome	0.000179	0.000962	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SUOX—polycystic ovary syndrome	0.000179	0.000962	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000178	0.000958	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000177	0.000952	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000177	0.000949	CbGpPWpGaD
Masoprocol—LTB4R—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000175	0.000941	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000175	0.00094	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000174	0.000931	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000171	0.000915	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000169	0.000908	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000167	0.000897	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000167	0.000897	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ISYNA1—polycystic ovary syndrome	0.000167	0.000894	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000164	0.000879	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000164	0.000879	CbGpPWpGaD
Masoprocol—IGF1R—Senescence and Autophagy in Cancer—IL6—polycystic ovary syndrome	0.000164	0.000879	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000163	0.000874	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000162	0.000868	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000162	0.000868	CbGpPWpGaD
Masoprocol—CYP19A1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000161	0.000864	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TEAD2—polycystic ovary syndrome	0.000159	0.000853	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000159	0.000853	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000158	0.000847	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000156	0.000839	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000154	0.000826	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—AR—polycystic ovary syndrome	0.000154	0.000825	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000153	0.00082	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000152	0.000816	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000152	0.000814	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00015	0.000807	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000148	0.000792	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—VEGFA—polycystic ovary syndrome	0.000147	0.00079	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000144	0.000774	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000144	0.000772	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000144	0.000772	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AKR1C2—polycystic ovary syndrome	0.000142	0.00076	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TEAD2—polycystic ovary syndrome	0.000142	0.00076	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000141	0.000756	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00014	0.00075	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000137	0.000737	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000136	0.000731	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000135	0.000726	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000134	0.000721	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000134	0.00072	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000133	0.000715	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000132	0.000706	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000131	0.000702	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00013	0.000698	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FST—polycystic ovary syndrome	0.000128	0.000688	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000127	0.000684	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000127	0.00068	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000126	0.000677	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LHB—polycystic ovary syndrome	0.000125	0.000671	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000124	0.000666	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000123	0.000662	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000122	0.000656	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000122	0.000656	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—STAR—polycystic ovary syndrome	0.00012	0.000646	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000119	0.000639	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000119	0.000637	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000118	0.000636	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000118	0.000634	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SCT—polycystic ovary syndrome	0.000117	0.000629	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000116	0.000621	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000115	0.000617	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000115	0.000616	CbGpPWpGaD
Masoprocol—CYP19A1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000113	0.000607	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000113	0.000604	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000112	0.0006	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000112	0.0006	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00011	0.00059	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000109	0.000585	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FST—polycystic ovary syndrome	0.000109	0.000585	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000109	0.000582	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000108	0.000578	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—STAR—polycystic ovary syndrome	0.000107	0.000576	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HMMR—polycystic ovary syndrome	0.000107	0.000576	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000107	0.000576	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LHB—polycystic ovary syndrome	0.000106	0.000571	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000106	0.000569	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000106	0.000567	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000104	0.000558	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000102	0.00055	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000102	0.000546	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000101	0.000543	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000101	0.000542	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000101	0.00054	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GAB1—polycystic ovary syndrome	0.0001	0.000539	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SCT—polycystic ovary syndrome	9.97e-05	0.000535	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	9.86e-05	0.000529	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	9.63e-05	0.000517	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—INSR—polycystic ovary syndrome	9.59e-05	0.000515	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.59e-05	0.000515	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HMMR—polycystic ovary syndrome	9.57e-05	0.000513	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MTNR1B—polycystic ovary syndrome	9.51e-05	0.00051	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	9.41e-05	0.000505	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—FGF18—polycystic ovary syndrome	9.35e-05	0.000502	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—LHB—polycystic ovary syndrome	9.34e-05	0.000501	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—RBP4—polycystic ovary syndrome	9.27e-05	0.000497	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—LPCAT2—polycystic ovary syndrome	9.23e-05	0.000495	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SUOX—polycystic ovary syndrome	9.23e-05	0.000495	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HSD3B1—polycystic ovary syndrome	9.13e-05	0.00049	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HSD3B2—polycystic ovary syndrome	9.13e-05	0.00049	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKR1C3—polycystic ovary syndrome	9.12e-05	0.000489	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	9.11e-05	0.000489	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.02e-05	0.000484	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TNRC6B—polycystic ovary syndrome	8.97e-05	0.000482	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PGR—polycystic ovary syndrome	8.88e-05	0.000477	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AKR1C1—polycystic ovary syndrome	8.84e-05	0.000474	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—YAP1—polycystic ovary syndrome	8.65e-05	0.000464	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ISYNA1—polycystic ovary syndrome	8.58e-05	0.000461	CbGpPWpGaD
Masoprocol—CYP19A1—Biological oxidations—POMC—polycystic ovary syndrome	8.55e-05	0.000459	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.55e-05	0.000459	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GAB1—polycystic ovary syndrome	8.53e-05	0.000458	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	8.39e-05	0.00045	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—LHB—polycystic ovary syndrome	8.32e-05	0.000447	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GHRL—polycystic ovary syndrome	8.26e-05	0.000443	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PLAT—polycystic ovary syndrome	8.26e-05	0.000443	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—INSR—polycystic ovary syndrome	8.16e-05	0.000438	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SULT2A1—polycystic ovary syndrome	8.13e-05	0.000437	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HSD3B2—polycystic ovary syndrome	8.13e-05	0.000437	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	7.97e-05	0.000428	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—POMC—polycystic ovary syndrome	7.96e-05	0.000427	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ATF1—polycystic ovary syndrome	7.88e-05	0.000423	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AKR1C1—polycystic ovary syndrome	7.88e-05	0.000423	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—RRM2—polycystic ovary syndrome	7.88e-05	0.000423	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	7.83e-05	0.00042	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKR1C3—polycystic ovary syndrome	7.75e-05	0.000416	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TCF7L2—polycystic ovary syndrome	7.68e-05	0.000412	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AKT2—polycystic ovary syndrome	7.65e-05	0.00041	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TNRC6B—polycystic ovary syndrome	7.63e-05	0.00041	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—YAP1—polycystic ovary syndrome	7.59e-05	0.000408	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PGR—polycystic ovary syndrome	7.55e-05	0.000405	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	7.43e-05	0.000399	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TEAD2—polycystic ovary syndrome	7.3e-05	0.000392	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AKR1C2—polycystic ovary syndrome	7.3e-05	0.000392	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NAMPT—polycystic ovary syndrome	7.3e-05	0.000392	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NGFR—polycystic ovary syndrome	7.27e-05	0.00039	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.25e-05	0.000389	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SULT2A1—polycystic ovary syndrome	7.25e-05	0.000389	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—POMC—polycystic ovary syndrome	7.23e-05	0.000388	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PRL—polycystic ovary syndrome	7.21e-05	0.000387	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP11A1—polycystic ovary syndrome	7.21e-05	0.000387	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.15e-05	0.000384	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PLAT—polycystic ovary syndrome	7.02e-05	0.000377	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GHRL—polycystic ovary syndrome	7.02e-05	0.000377	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—RRM2—polycystic ovary syndrome	7.02e-05	0.000377	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	7.02e-05	0.000377	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.95e-05	0.000373	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	6.91e-05	0.000371	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.84e-05	0.000367	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AKR1C3—polycystic ovary syndrome	6.8e-05	0.000365	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—YAP1—polycystic ovary syndrome	6.77e-05	0.000363	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ATF1—polycystic ovary syndrome	6.7e-05	0.00036	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP17A1—polycystic ovary syndrome	6.7e-05	0.00036	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TCF7L2—polycystic ovary syndrome	6.53e-05	0.000351	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NAMPT—polycystic ovary syndrome	6.5e-05	0.000349	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.46e-05	0.000347	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP11A1—polycystic ovary syndrome	6.42e-05	0.000345	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.38e-05	0.000342	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GNAS—polycystic ovary syndrome	6.34e-05	0.00034	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NGFR—polycystic ovary syndrome	6.18e-05	0.000332	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PRL—polycystic ovary syndrome	6.13e-05	0.000329	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PNPLA2—polycystic ovary syndrome	6.11e-05	0.000328	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AKR1C3—polycystic ovary syndrome	6.06e-05	0.000325	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.04e-05	0.000324	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP17A1—polycystic ovary syndrome	5.97e-05	0.00032	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	5.96e-05	0.00032	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NRG1—polycystic ovary syndrome	5.93e-05	0.000318	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADRB2—polycystic ovary syndrome	5.81e-05	0.000312	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SRD5A1—polycystic ovary syndrome	5.8e-05	0.000311	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TH—polycystic ovary syndrome	5.8e-05	0.000311	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—SLC2A4—polycystic ovary syndrome	5.64e-05	0.000303	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—STAR—polycystic ovary syndrome	5.53e-05	0.000297	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GNAS—polycystic ovary syndrome	5.39e-05	0.000289	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP19A1—polycystic ovary syndrome	5.3e-05	0.000285	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TH—polycystic ovary syndrome	5.17e-05	0.000277	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NCOR1—polycystic ovary syndrome	5.13e-05	0.000276	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IRS2—polycystic ovary syndrome	5.08e-05	0.000273	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NRG1—polycystic ovary syndrome	5.04e-05	0.000271	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—SLC2A4—polycystic ovary syndrome	5.03e-05	0.00027	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LEP—polycystic ovary syndrome	4.97e-05	0.000267	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HMMR—polycystic ovary syndrome	4.93e-05	0.000265	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GNAS—polycystic ovary syndrome	4.73e-05	0.000254	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP19A1—polycystic ovary syndrome	4.72e-05	0.000254	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HSD3B1—polycystic ovary syndrome	4.7e-05	0.000252	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.65e-05	0.000249	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NCOR1—polycystic ovary syndrome	4.51e-05	0.000242	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IRS1—polycystic ovary syndrome	4.43e-05	0.000238	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.41e-05	0.000236	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IRS2—polycystic ovary syndrome	4.32e-05	0.000232	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—LHB—polycystic ovary syndrome	4.29e-05	0.00023	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP1A1—polycystic ovary syndrome	4.27e-05	0.000229	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—POMC—polycystic ovary syndrome	4.27e-05	0.000229	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—INS—polycystic ovary syndrome	4.24e-05	0.000228	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LEP—polycystic ovary syndrome	4.22e-05	0.000227	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GNAS—polycystic ovary syndrome	4.22e-05	0.000226	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HSD3B2—polycystic ovary syndrome	4.19e-05	0.000225	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF1—polycystic ovary syndrome	4.11e-05	0.00022	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT2—polycystic ovary syndrome	4.1e-05	0.00022	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AKR1C1—polycystic ovary syndrome	4.06e-05	0.000218	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NCOR1—polycystic ovary syndrome	4.02e-05	0.000216	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MTHFR—polycystic ovary syndrome	3.98e-05	0.000214	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.9e-05	0.000209	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP1A1—polycystic ovary syndrome	3.81e-05	0.000204	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IRS1—polycystic ovary syndrome	3.77e-05	0.000202	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SULT2A1—polycystic ovary syndrome	3.73e-05	0.0002	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—POMC—polycystic ovary syndrome	3.63e-05	0.000195	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—RRM2—polycystic ovary syndrome	3.62e-05	0.000194	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—INS—polycystic ovary syndrome	3.61e-05	0.000194	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MTHFR—polycystic ovary syndrome	3.55e-05	0.000191	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IGF1—polycystic ovary syndrome	3.49e-05	0.000187	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT2—polycystic ovary syndrome	3.49e-05	0.000187	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—YAP1—polycystic ovary syndrome	3.49e-05	0.000187	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NAMPT—polycystic ovary syndrome	3.35e-05	0.00018	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.33e-05	0.000179	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.32e-05	0.000178	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP11A1—polycystic ovary syndrome	3.31e-05	0.000178	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.28e-05	0.000176	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PPARG—polycystic ovary syndrome	3.23e-05	0.000173	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—POMC—polycystic ovary syndrome	3.19e-05	0.000171	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—INS—polycystic ovary syndrome	3.17e-05	0.00017	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6—polycystic ovary syndrome	3.14e-05	0.000169	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AKR1C3—polycystic ovary syndrome	3.12e-05	0.000168	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP17A1—polycystic ovary syndrome	3.08e-05	0.000165	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPARG—polycystic ovary syndrome	2.88e-05	0.000155	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—POMC—polycystic ovary syndrome	2.84e-05	0.000152	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—INS—polycystic ovary syndrome	2.82e-05	0.000152	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.68e-05	0.000144	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TH—polycystic ovary syndrome	2.66e-05	0.000143	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.59e-05	0.000139	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.28e-05	0.000122	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	2.17e-05	0.000117	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	2.07e-05	0.000111	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.96e-05	0.000105	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6—polycystic ovary syndrome	1.85e-05	9.95e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	1.83e-05	9.82e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6—polycystic ovary syndrome	1.58e-05	8.46e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	1.48e-05	7.96e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	1.46e-05	7.85e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—INS—polycystic ovary syndrome	1.45e-05	7.81e-05	CbGpPWpGaD
